Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Source: Pixabay.com

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

  Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…

Continue Reading Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
source: pixabay.com

1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases

Leszek Ignatowicz, a researcher from Georgia State University, recently received a 5 year, almost 2 million dollar grant from the NIH for his investigation into multiple sclerosis (MS). This project…

Continue Reading 1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
source: pixabay.com

Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment

FightMND is an Australian nonprofit organization dedicated to improving the lives of motor neurone disease patients through funding research for cures. They've successfully provided millions toward research initiatives and clinical…

Continue Reading Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
source: pixabay.com

Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss

According to a story from Medical Xpress, a team of researchers from the medical school at the University of Massachusetts has revealed new information about the nature of neurodegenerative symptoms…

Continue Reading Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss